erectile-dysfunction

Glaxo and marketers of other erectile-dysfunction drugs, including Pfizer's Viagra and Eli Lilly & Co.'s Cialis, have been criticized over the past decade for airing TV commercials with sexually suggestive themes and explicit discussions of potential side effects during times when children may be watching.

Glaxo Pulls Some Ads, Citing Image Peter Loftus 2011

Lilly sees continued sales growth for Cymbalta, erectile-dysfunction drug Cialis, and diabetes drugs Humalog and Humulin.

For Lilly, Rocky Year Ahead Peter Loftus 2012

In the past, most drug-counterfeiting incidents have involved pills such as the erectile-dysfunction medicine Viagra, the most commonly faked drug, according to its maker, Pfizer Inc., with more than 9.5 million bogus tablets seized last year.

Fakes Infiltrate Injectable Drugs Jonathan D. Rockoff 2012

Sales rose for anti-inflammatory drug Enbrel, pain treatments Lyrica and Celebrex, and erectile-dysfunction drug Viagra.

Pfizer Profit Rises 5.5% Peter Loftus 2011

Sales of pain-drug Celebrex rose 4%, while erectile-dysfunction drug Viagra fell 2%.

Pfizer's Profit Rises 10% Amid Lower Costs Peter Loftus 2011

The violation feels bigger, more insidious than hawkers of dish detergent and erectile-dysfunction medication simply trying to make sure you hear their message from the bathroom during halftime at the Super Bowl.

TV's Sound and Fury Ralph Gardner Jr. 2011

CVS Caremark also recommended plans stop covering the erectile-dysfunction treatment Levitra, which is made by Bayer AG and sold in the U.S. by GlaxoSmithKline PLC, in favor of Pfizer's Viagra and Eli Lilly's Cialis.

CVS Disfavors Some Drugs Jon Kamp 2011

CVS Caremark Corp.'s pharmacy-benefit business is recommending customers stop covering more than 30 drugs next year, including diabetes treatments and an erectile-dysfunction pill, to save money and combat drug-maker coupons that promote brand-name medicine over cheaper alternatives.

CVS Disfavors Some Drugs Jon Kamp 2011

While products that hit the shelves in Japan last year were first available six to eight years ago elsewhere, Mr. Lechleiter said Lilly has made progress in working with the Minister of Health and Welfare here to get approvals for launches closer to the same time in Japan as elsewhere, as with erectile-dysfunction treatment Cialis.

Eli Lilly Back on Growth Track Kenneth Maxwell 2011

One possible reason, she said, was the surge in use of erectile-dysfunction drugs by men.

It’s All Downhill After Age 45 According to an AARP Sex Survey | Impact Lab 2010